In vitro and in vivo comparison of gemcitabine and the gemcitabine analog 1-(2′-deoxy-2′-fluoroarabinofuranosyl) cytosine (FAC) in human orthotopic and genetically modified mouse pancreatic cancer models Journal Article
| Authors: | Russell, J.; Pillarsetty, N.; Kramer, R. M.; Romesser, P. B.; Desai, P.; Haimovitz-Friedman, A.; Lowery, M. A.; Humm, J. L. |
| Article Title: | In vitro and in vivo comparison of gemcitabine and the gemcitabine analog 1-(2′-deoxy-2′-fluoroarabinofuranosyl) cytosine (FAC) in human orthotopic and genetically modified mouse pancreatic cancer models |
| Abstract: | Purpose: Although gemcitabine is a mainstay of pancreatic cancer therapy, it is only moderately effective, and it would be desirable to measure drug uptake in patients. 1-(2′-deoxy-2′-fluoroarabinofuranosyl) cytosine (FAC), is an analog of gemcitabine, and when labeled with F-18, it may be a potential surrogate PET tracer for the drug. Procedures: [18F]FAC was synthesized to a radiochemical purity of >96 %. The human tumor lines AsPC1, BxPC3, Capan-1, Panc1, and MiaPaca2 were grown orthotopically in nude mice. KPC mice that conditionally express oncogenic K-ras and p53 mutations in pancreatic tissue were also used. The intra-tumoral distributions of [14C]gemcitabine and [18F]FAC were mapped with autoradiography. The inter-tumor correlation between [14C]gemcitabine and [18F]FAC was established in the orthotopic tumors. Expression of the equilibrative and concentrative nucleoside transporters (ENT, CNT) in vitro was detected by western blotting. Drug uptake was characterized in vitro using [3H]gemcitabine and the effect of transporter inhibition on gemcitabine and FAC uptake was investigated. The relative affinity of cells for gemcitabine and FAC was tested in competition assays. The cell lines differed in sensitivity to transport inhibitors and in competition studies. There was a good in vivo correlation between the total uptake of [18F]FAC and [14C]gemcitabine, measured across all orthotopic tumors. Using the KPC and BxPC3 models, we found that [14C]gemcitabine and [18F]FAC were largely co-localized. Conclusions: In the lines examined here, [18F]FAC uptake correlates well with gemcitabine in vivo, supporting the notion that [18F]FAC can serve as a PET radiotracer surrogate to determine the uptake and distribution of gemcitabine within pancreatic tumors. © 2017, World Molecular Imaging Society. |
| Keywords: | protein expression; unclassified drug; human cell; nonhuman; gemcitabine; pancreas cancer; mouse; animal tissue; animal experiment; animal model; in vivo study; in vitro study; protein p53; drug uptake; western blotting; radiopharmaceutical agent; pancreatic cancer; k ras protein; radiochemistry; cytosine; drug analog; human; female; priority journal; article; nucleoside transporter; fac; 1 (2' deoxy 2 fluoroarabinofuranosyl) cytosine f 18; gemcitabine c 14; pancreas tissue |
| Journal Title: | Molecular Imaging and Biology |
| Volume: | 19 |
| Issue: | 6 |
| ISSN: | 1536-1632 |
| Publisher: | Springer |
| Date Published: | 2017-12-01 |
| Start Page: | 885 |
| End Page: | 892 |
| Language: | English |
| DOI: | 10.1007/s11307-017-1078-6 |
| PROVIDER: | scopus |
| PMCID: | PMC5696795 |
| PUBMED: | 28349292 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 December 2017 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work